HBIO harvardbioscience.com: Nilai perusahaan marang pendapatan

Harvard Bioscience maintains an impeccable reputation as a global leader in the biomedical equipment sector. The company develops advanced microfluidic chips and organ-on-a-chip systems for pharmacology. Stable demand for consumables provides the business with a reliable cash flow. The EV/Sales valuation demonstrates debt-free value dynamics, where 885.02 expresses the current level of the metric.
HBIO (harvardbioscience.com): rincian analitis lan laporan miturut indikator

This indicator measures the enterprise value, including debt and excluding cash, relative to annual sales to determine the asset's market overvaluation. By analyzing the EV/Sales valuation of Harvard Bioscience (HBIO) on the GURU.Markets platform, an investor can see how the premium positioning of Harvard Bioscience (HBIO) in the electrophysiology segment and the loyalty of the scientific community support a high enterprise value relative to generated revenue.